Lv2
125 积分 2025-01-09 加入
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
17天前
已完结
[Lambert-Eaton Myasthenic Syndrome]
20天前
已关闭
Lambert-Eaton myasthenic syndrome
20天前
已完结
Contribution of the glomerular filtration rate slope to the kidney hierarchical composite endpoint
1个月前
已关闭
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1个月前
已完结
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
2个月前
已完结
Combination Therapies in Locally Advanced and Metastatic Hormone-sensitive Prostate Cancer
2个月前
已完结
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
2个月前
已完结
Relugolix for the treatment of prostate cancer
2个月前
已完结
Treatments and challenges in advanced prostate cancer
2个月前
已完结
皖公网安备34019202002308
